DMazur Headshot

Derek Mazur Senior Associate

Derek joined Santé Ventures in 2014. Prior to joining the firm, Derek was with Houlihan Lokey in their Healthcare Mergers & Acquisitions practice based in Chicago. Before Houlihan, Derek was in the Investment Banking Division at SunTrust Robinson Humphrey based in Atlanta, where he focused on a variety of syndicated & leveraged finance, capital markets, and financial advisory engagements. Derek currently serves as a Board Observer at Iterion Therapeutics, a clinical stage oncology company. Derek is completing a Masters of Science in Biotechnology from Johns Hopkins University, and received a Bachelors of Business Administration in Finance from Emory University.

News
December 27, 2018 Boston Scientific Exercises Option to Acquire Millipede, Inc. for $540M (Santé Ventures Leads Deal as Only Institutional Investor)
Read More
December 5, 2018 Iterion Therapeutics Initiates Phase I Clinical Study of Tegavivint in Patients with Desmoid Tumors
Read More